Kestra Advisory Services’s Nuvation Bio NUVB Stock Holding History
Bought
Maintained
Sold
Other funds holding NUVB
Kestra Advisory Services's NUVB Position: Q3 2026 in Review
Kestra Advisory Services reduced its Nuvation Bio (NUVB) stake by 11% in Q3 2026, selling an estimated $13.8K and leaving 17,148 shares worth $96K. The position accounts for ﹤0.01% of the portfolio, ranked #3355.
Kestra Advisory Services first reported a position in NUVB in Q4 2025 and has held it in 3 quarters since. The position peaked at $110K in Q2 2026. 254 funds tracked by Wall St. Rank hold NUVB as of Q3 2026.
- Kestra Advisory Services held 17,148 shares of Nuvation Bio worth $96K as of Q3 2026.
- Kestra Advisory Services sold 2,192 Nuvation Bio shares in Q3 2026, an estimated $13.8K.
- Nuvation Bio made up ﹤0.01% of Kestra Advisory Services's portfolio in Q3 2026, its #3355 holding.
- Kestra Advisory Services first reported a position in Nuvation Bio in Q4 2025 and has held it in 3 quarters since.
- Kestra Advisory Services's Nuvation Bio position peaked at $110K in Q2 2026.
- 254 funds tracked by Wall St. Rank held Nuvation Bio as of Q3 2026.
Based on Kestra Advisory Services's 13F filing for Q3 2026, filed 2 Nov 2026.